Incannex Healthcare Inc. (IXHL): EPS (Basic)
-$1.66
Year ended 2026-06-30
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$1.66 | n/m | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | -$40.82 | n/c | 2026-09-25, From 2024-07-01 |
| 2024-06-30 | -$1.15 | n/m | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | -$3.32 | n/a | 2024-09-30, From 2022-07-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | 2026-06-30 | -$1.66 | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $3.73 | -51.4% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $3.47 | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$0.05 | n/m |
| Eli Lilly & Co (LLY) | 2025-12-31 | $23.00 | +95.6% |
| Pfizer Inc (PFE) | 2025-12-31 | $1.37 | -3.5% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $11.13 | +90.6% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $1.08 | +163.4% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $7.30 | +8.0% |
Compare IXHL, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗